April 05, 2024
A class of investors suing Perrigo Co. PLC asked a New Jersey federal judge Friday to approve a $97 million settlement after the court trimmed several claims in the suit alleging the pharmaceutical company's executives made misleading statements to defeat a potential $29 billion takeover attempt.
August 18, 2023
A New Jersey federal judge has further cut back an already diminished class action against pharmaceutical company Perrigo, accusing shareholders of "warping" the words of a former CEO in an unsuccessful attempt to prove that he knew about a purported price-fixing scheme at the company.